Use of Genetically Modified Lactic Acid Bacteria and Bifidobacteria As Live Delivery Vectors for Human and Animal Health

Overview

Journal Gut Microbes

Specialties Gastroenterology
Microbiology

Date 2022 Aug 12

PMID 35960855

Authors

Romina Levit

Naima G Cortes-Perez

Alejandra de Moreno de LeBlanc

Jade Loiseau

Anne Aucouturier

Philippe Langella

Jean Guy LeBlanc

Luis G Bermudez-Humaran

Affiliations

Soon will be listed here.

Abstract

There is now strong evidence to support the interest in using lactic acid bacteria (LAB)in particular, strains of lactococci and lactobacilli, as well as bifidobacteria, for the development of new live vectors for human and animal health purposes. LAB are Gram-positive bacteria that have been used for millennia in the production of fermented foods. In addition, numerous studies have shown that genetically modified LAB and bifodobacteria can induce a systemic and mucosal immune response against certain antigens when administered mucosally. They are therefore good candidates for the development of new mucosal delivery strategies and are attractive alternatives to vaccines based on attenuated pathogenic bacteria whose use presents health risks. This article reviews the most recent research and advances in the use of LAB and bifidobacteria as live delivery vectors for human and animal health.

Citing Articles

BD400 protects from collagen-induced arthritis through histidine metabolism.

Yang Y, Hong Q, Zhang X, Liu Z Front Immunol. 2025; 16:1518181.

PMID: 39911381 PMC: 11794514. DOI: 10.3389/fimmu.2025.1518181.

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders.

Song Y, Li J, Wu Y Signal Transduct Target Ther. 2024; 9(1):263.

PMID: 39362875 PMC: 11452214. DOI: 10.1038/s41392-024-01952-8.

Oral Live-Carrier Vaccine of Recombinant Lactococcus lactis Inducing Prophylactic Protective Immunity Against Helicobacter pylori Infection.

Ni X, Liu Y, Sun M, Jiang Y, Wang Y, Ke D Probiotics Antimicrob Proteins. 2024; .

PMID: 39251521 DOI: 10.1007/s12602-024-10360-x.

Lactic acid production by using a sequence of seasonally available fruit wastes as sustainable carbon sources.

Costa S, Summa D, Radice M, Vertuani S, Manfredini S, Tamburini E Front Bioeng Biotechnol. 2024; 12:1447278.

PMID: 39157446 PMC: 11327009. DOI: 10.3389/fbioe.2024.1447278.

Recombinant probiotic delivering P62 mitigates moderate colitis in mice.

Laguna J, Dos Santos Freitas A, Barroso F, Lima de Jesus L, De Vasconcelos O, Quaresma L Front Microbiol. 2024; 15:1309160.

PMID: 38680913 PMC: 11047439. DOI: 10.3389/fmicb.2024.1309160.

References

Wu C, Bermudez-Humaran L, Yue F, Li M, Zhang L . Intranasal administration with recombinant Lactococcus lactis expressing heme oxygenase-1 reduces hyperoxia-induced lung inflammation in rat pups. Biotechnol Lett. 2015; 37(6):1203-11. DOI: 10.1007/s10529-015-1795-3. View

Rezaei M, Rabbani-Khorasgani M, Zarkesh-Esfahani S, Emamzadeh R, Abtahi H . Lactococcus-based vaccine against brucellosis: IgG immune response in mice with rOmp16-IL2 fusion protein. Arch Microbiol. 2021; 203(5):2591-2596. DOI: 10.1007/s00203-021-02241-6. View

Le Loir Y, Gruss A, Ehrlich S, Langella P . A nine-residue synthetic propeptide enhances secretion efficiency of heterologous proteins in Lactococcus lactis. J Bacteriol. 1998; 180(7):1895-903. PMC: 107105. DOI: 10.1128/JB.180.7.1895-1903.1998. View

Ebrahimzadeh F, Shirdast H, Taromchi A, Talebkhan Y, Haniloo A, Esmaeilzadeh A . Induction of Immunogenic Response in BALB/c Mice by Live and Killed Form of Recombinant Lactococcus lactis Displaying EG95 of Echinococcus granulosus. Iran Biomed J. 2021; 25(4):284-96. PMC: 8334390. DOI: 10.52547/ibj.25.4.284. View

Ai C, Zhang Q, Ren C, Wang G, Liu X, Tian F . Genetically engineered Lactococcus lactis protect against house dust mite allergy in a BALB/c mouse model. PLoS One. 2014; 9(10):e109461. PMC: 4188596. DOI: 10.1371/journal.pone.0109461. View

Hou X, Yu L, Liu J, Wang G . Surface-displayed porcine epidemic diarrhea viral (PEDV) antigens on lactic acid bacteria. Vaccine. 2007; 26(1):24-31. PMC: 7115547. DOI: 10.1016/j.vaccine.2007.10.065. View

Bolotin A, Wincker P, Mauger S, Jaillon O, Malarme K, Weissenbach J . The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res. 2001; 11(5):731-53. PMC: 311110. DOI: 10.1101/gr.gr-1697r. View

Young Chung J, Thone M, Kwon Y . COVID-19 vaccines: The status and perspectives in delivery points of view. Adv Drug Deliv Rev. 2020; 170:1-25. PMC: 7759095. DOI: 10.1016/j.addr.2020.12.011. View

Watterlot L, Rochat T, Sokol H, Cherbuy C, Bouloufa I, Lefevre F . Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int J Food Microbiol. 2010; 144(1):35-41. DOI: 10.1016/j.ijfoodmicro.2010.03.037. View

10.

Szatraj K, Szczepankowska A, Chmielewska-Jeznach M . Lactic acid bacteria - promising vaccine vectors: possibilities, limitations, doubts. J Appl Microbiol. 2017; 123(2):325-339. PMC: 7166332. DOI: 10.1111/jam.13446. View

11.

Yamamoto S, Wada J, Katayama T, Jikimoto T, Nakamura M, Kinoshita S . Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model. Vaccine. 2010; 28(41):6684-91. DOI: 10.1016/j.vaccine.2010.08.007. View

12.

Piard J, Hautefort I, Fischetti V, Ehrlich S, Fons M, Gruss A . Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria. J Bacteriol. 1997; 179(9):3068-72. PMC: 179078. DOI: 10.1128/jb.179.9.3068-3072.1997. View

13.

Shirakawa T, Kitagawa K . Antitumor effect of oral cancer vaccine with Bifidobacterium delivering WT1 protein to gut immune system is superior to WT1 peptide vaccine. Hum Vaccin Immunother. 2017; 14(1):159-162. PMC: 5791589. DOI: 10.1080/21645515.2017.1382787. View

14.

Shonyela S, Shi C, Yang W, Cao X, Yang G, Wang C . Recombinant Lactobacillus plantarum NC8 strain expressing porcine rotavirus VP7 induces specific antibodies in BALB/c mice. Acta Biochim Biophys Sin (Shanghai). 2021; 53(6):707-718. DOI: 10.1093/abbs/gmab050. View

15.

Cesta M . Normal structure, function, and histology of mucosa-associated lymphoid tissue. Toxicol Pathol. 2006; 34(5):599-608. DOI: 10.1080/01926230600865531. View

16.

Quintana I, Espariz M, Villar S, Gonzalez F, Pacini M, Cabrera G . Genetic Engineering of Co-producing Antigen and the Mucosal Adjuvant 3' 5'- cyclic di Adenosine Monophosphate (c-di-AMP) as a Design Strategy to Develop a Mucosal Vaccine Prototype. Front Microbiol. 2018; 9:2100. PMC: 6143824. DOI: 10.3389/fmicb.2018.02100. View

17.

Bermudez-Humaran L . Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins. Hum Vaccin. 2009; 5(4):264-7. DOI: 10.4161/hv.5.4.7553. View

18.

Moradi-Kalbolandi S, Majidzadeh-A K, Haji Abdolvahab M, Jalili N, Farahmand L . The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development. Probiotics Antimicrob Proteins. 2021; 13(5):1239-1253. PMC: 7996120. DOI: 10.1007/s12602-021-09773-9. View

19.

Bermudez-Humaran L, Kharrat P, Chatel J, Langella P . Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines. Microb Cell Fact. 2011; 10 Suppl 1:S4. PMC: 3231930. DOI: 10.1186/1475-2859-10-S1-S4. View

20.

Metzger D . IL-12 as an adjuvant for the enhancement of protective humoral immunity. Expert Rev Vaccines. 2009; 8(5):515-8. DOI: 10.1586/erv.09.13. View